- Home
- BIIB vs PPG Comparison
BIIB vs PPG Comparison
Compare BIIB & PPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIIB
- PPG
- Stock Information
- Founded
- BIIB 1978
- PPG 1883
- Country
- BIIB United States
- PPG United States
- Employees
- BIIB N/A
- PPG N/A
- Industry
- BIIB Biotechnology: Pharmaceutical Preparations
- PPG Paints/Coatings
- Sector
- BIIB Health Care
- PPG Consumer Discretionary
- Exchange
- BIIB Nasdaq
- PPG Nasdaq
- Market Cap
- BIIB 25.1B
- PPG 28.8B
- IPO Year
- BIIB 1991
- PPG N/A
- Fundamental
- Price
- BIIB $148.76
- PPG $120.98
- Analyst Decision
- BIIB Buy
- PPG Buy
- Analyst Count
- BIIB 26
- PPG 17
- Target Price
- BIIB $248.00
- PPG $149.21
- AVG Volume (30 Days)
- BIIB 1.6M
- PPG 2.2M
- Earning Date
- BIIB 02-11-2025
- PPG 01-16-2025
- Dividend Yield
- BIIB N/A
- PPG 2.25%
- EPS Growth
- BIIB 10.05
- PPG 5.55
- EPS
- BIIB 11.06
- PPG 6.30
- Revenue
- BIIB $9,607,500,000.00
- PPG $18,030,000,000.00
- Revenue This Year
- BIIB N/A
- PPG N/A
- Revenue Next Year
- BIIB N/A
- PPG N/A
- P/E Ratio
- BIIB $13.47
- PPG $19.20
- Revenue Growth
- BIIB N/A
- PPG N/A
- 52 Week Low
- BIIB $145.07
- PPG $118.07
- 52 Week High
- BIIB $268.30
- PPG $150.82
- Technical
- Relative Strength Index (RSI)
- BIIB 32.44
- PPG 41.48
- Support Level
- BIIB $145.07
- PPG $118.58
- Resistance Level
- BIIB $149.92
- PPG $124.81
- Average True Range (ATR)
- BIIB 3.81
- PPG 2.56
- MACD
- BIIB 0.05
- PPG -0.39
- Stochastic Oscillator
- BIIB 22.51
- PPG 20.92
About BIIB Biogen Inc.
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.
About PPG PPG Industries Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.